Western blot analysis indicated that DPI/CB11 treatment blocked CB11-mediated p-ATM, p-p53, GADD45α, and cleaved caspase-3 expression in NSCLC cells, but DPI/NAC did not (Fig. 4e). This evidence concerns the gene TP53 and non-small cell lung carcinoma.